Market Overview

UPDATE: JP Morgan Initiates Cerner at Overweight on Leadership, Outlook

Related CERN
Top 4 NASDAQ Stocks In The Healthcare Information Services Industry With The Highest Revenue
#PreMarket Primer: Thursday, September 4: Talk Of A Ceasefire In Ukraine
This Is What a Growth Stock Looks Like (Fox Business)

JP Morgan initiated coverage on Cerner (NASDAQ: CERN) with an Overweighr rating and a $93 price target

JP Morgan commented, "In the large hospital market (>200 beds), Cerner has ~21% market share of clinical systems, just behind privately-held Epic. Cerner has been gaining share in recent years, improving from just 15% market share in 2005, while competitors have been losing ground. The top 3 clinical system vendors account for 65% of the market, yet we believe dissatisfaction with other large vendors should create opportunities for market share gains for Cerner."

Cerner closed at $80.45 on Wednesday.

Latest Ratings for CERN

DateFirmActionFromTo
Sep 2014Topeka CapitalMaintainsBuy
Aug 2014Wells FargoUpgradesMarket PerformOutperform
Jul 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CERN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters